
Shingles Vaccine Linked to Lower Dementia Risk, Early Studies Hint
New studies suggest the Shingrix shingles vaccine may be associated with a lower risk of dementia in older adults, with some research indicating about a 50% reduction in risk among vaccinated individuals. In addition to preventing shingles and its serious complications like postherpetic neuralgia, the vaccine may also modestly lower risks of heart attack and stroke. The CDC recommends two doses for adults 50+, with dosing intervals of two to six months, and stronger immune responses are reported in older adults. Side effects are usually mild, and vaccination rates for adults over 60 remain around 35%; more research is needed to establish causality between vaccination and dementia protection.













